DE69517048T2 - Hilfsmittel zum löschmachen von hydrophylen makromolekülen - Google Patents

Hilfsmittel zum löschmachen von hydrophylen makromolekülen

Info

Publication number
DE69517048T2
DE69517048T2 DE69517048T DE69517048T DE69517048T2 DE 69517048 T2 DE69517048 T2 DE 69517048T2 DE 69517048 T DE69517048 T DE 69517048T DE 69517048 T DE69517048 T DE 69517048T DE 69517048 T2 DE69517048 T2 DE 69517048T2
Authority
DE
Germany
Prior art keywords
hydrophylene
macromolecules
extinguishing
tools
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69517048T
Other languages
English (en)
Other versions
DE69517048D1 (de
Inventor
Randal New
John Kirby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provalis UK Ltd
Original Assignee
Provalis UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis UK Ltd filed Critical Provalis UK Ltd
Publication of DE69517048D1 publication Critical patent/DE69517048D1/de
Application granted granted Critical
Publication of DE69517048T2 publication Critical patent/DE69517048T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lift Valve (AREA)
  • General Preparation And Processing Of Foods (AREA)
DE69517048T 1994-12-09 1995-12-08 Hilfsmittel zum löschmachen von hydrophylen makromolekülen Expired - Fee Related DE69517048T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424902.6A GB9424902D0 (en) 1994-12-09 1994-12-09 Solubilisation Aids
PCT/GB1995/002891 WO1996017593A1 (en) 1994-12-09 1995-12-08 Solubilisation aids for hydrophilic macromolecules

Publications (2)

Publication Number Publication Date
DE69517048D1 DE69517048D1 (de) 2000-06-21
DE69517048T2 true DE69517048T2 (de) 2000-09-14

Family

ID=10765694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69517048T Expired - Fee Related DE69517048T2 (de) 1994-12-09 1995-12-08 Hilfsmittel zum löschmachen von hydrophylen makromolekülen

Country Status (14)

Country Link
US (1) US5968549A (de)
EP (1) EP0796085B1 (de)
JP (1) JPH10510256A (de)
CN (1) CN1169113A (de)
AT (1) ATE192920T1 (de)
AU (1) AU4122496A (de)
CA (1) CA2207279A1 (de)
DE (1) DE69517048T2 (de)
FI (1) FI972442A (de)
GB (1) GB9424902D0 (de)
IL (1) IL116313A0 (de)
NO (1) NO972608L (de)
WO (1) WO1996017593A1 (de)
ZA (1) ZA9510508B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
GB9521806D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Preservation methods
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
TW518219B (en) * 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2002515757A (ja) * 1997-02-07 2002-05-28 ケイ・アイ化成株式会社 水媒介による、安定なビタミンｃ誘導体の強化によって、水生生物の成長及び生存率を高める方法
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO2000033866A1 (en) * 1998-12-04 2000-06-15 Provalis Uk Limited Pharmaceutical compositions containing insulin
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
EP1731139A4 (de) * 2004-03-31 2008-12-03 Aspion Co Ltd Pharmazeutische zubereitung vom s/o typ und herstellungsverfahren dafür
KR101376895B1 (ko) 2004-05-03 2014-03-25 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
CN101027318B (zh) 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物，制剂及其用途
JP4843494B2 (ja) * 2004-08-31 2011-12-21 Ｓｏファーマ株式会社 Ｓ／ｏ型外用剤
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
WO2009050738A2 (en) 2007-10-16 2009-04-23 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
MX2018004328A (es) 2015-10-16 2018-08-01 Ipsen Biopharm Ltd Composiciones farmaceuticas estabilizantes de camptotecina.
KR102067094B1 (ko) 2018-04-17 2020-01-15 김철환 비(非)계면활성제형 오일-물(o/w) 분산 조성물, 비(非)계면활성제형 물-오일(w/o) 분산 조성물 및 이들의 제조방법
CN110215740B (zh) * 2019-07-15 2021-05-04 大连医科大学 一种两性离子亲水前处理硅胶材料的制备方法
CN111888475B (zh) * 2020-07-24 2022-01-07 华中科技大学 缓控释制剂及制法与制备原位肿瘤免疫联合治疗药物应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
CN1169113A (zh) 1997-12-31
GB9424902D0 (en) 1995-02-08
AU4122496A (en) 1996-06-26
JPH10510256A (ja) 1998-10-06
FI972442A0 (fi) 1997-06-09
ZA9510508B (en) 1997-06-11
NO972608L (no) 1997-08-08
NO972608D0 (no) 1997-06-06
DE69517048D1 (de) 2000-06-21
EP0796085B1 (de) 2000-05-17
MX9704274A (es) 1997-09-30
IL116313A0 (en) 1996-03-31
FI972442A (fi) 1997-06-09
ATE192920T1 (de) 2000-06-15
WO1996017593A1 (en) 1996-06-13
US5968549A (en) 1999-10-19
EP0796085A1 (de) 1997-09-24
CA2207279A1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
DE69517048D1 (de) Hilfsmittel zum löschmachen von hydrophylen makromolekülen
DE3679128D1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
BR0207776A (pt) Derivado de esterol, lipossomos compreendendo o mesmo, método de carga dos referidos lipossomos e uso dos mesmos
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
DE69738154D1 (de) Optische auflösung von methylphenidat mittels 0,0'-bisaroyl-weinsäuren
AU4101589A (en) Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
BR0114884A (pt) Compostos calcilìticos
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IT1228537B (it) Derivati della cisteina ad azione espettorante
ATE239017T1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
DE69803528T2 (de) Verfahren zum Herstellen von optisch aktiver 2-Hydroxymethyl-3-phenylpropionsäure
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DE69834811D1 (de) Pelargonsäurevanillylamid enthaltendes tränengas
WO2001021765A3 (en) METHOD FOR THE SELECTIVE PROTECTION OF PROLIFERATING NORMAL CELLS AND THE SELECTIVE ERADICATION OF TUMOR CELLS HAVING AN INACTIVE p53 PATHWAY
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
DE69827120D1 (de) Verfahren zur entfernung von hochsiedenden lösemitteln aus wirkstoffformulierungen mittels vakuum trocknung
DE59904931D1 (de) Verfahren zur Herstellung von 2-Methyl-1,3-dicarbonsäureestern

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee